24/7 Market News Snapshot 20 Jun 2024 – Clearmind Medicine Inc. Common Shares (NASDAQ: CMND)

June 20, 2024 7:02

Press Release

DENVER, Colo., 20 June, 2024 (247marketnews.com) – (Nasdaq:CMND) are discussed in this article.
Clearmind Medicine Inc. (CMND) emerges as a beacon of promise in the market, soaring by an impressive 78.29% to reach $2.218 in pre-market trading, amidst a substantial trading volume of 3.4 million shares. This surge underscores a positive investor outlook and signifies a potential uptrend following a notable increase from the previous session’s close price of $1.23. Investors are eagerly monitoring CMND as it continues to outperform expectations, positioning it as a compelling prospect for lucrative opportunities.

In a strategic development, Clearmind Medicine Inc. has secured an exclusive patent licensing agreement with Yissum Research Development Company of the Hebrew University of Jerusalem, marking a significant leap towards addressing under-treated health issues. This collaboration grants CMND global exclusivity to advance the development, production, and commercialization of groundbreaking compounds designed by esteemed professors from the Hebrew University, presenting innovative solutions for mental health conditions, notably post-traumatic stress disorder (PTSD).

By harnessing the expertise and research prowess of the Hebrew University, Clearmind Medicine underscores its dedication to pioneering psychedelic-derived therapeutics. This alliance heralds a new era of research and innovation, poised to reshape the treatment landscape for mental health disorders and offer hope to individuals grappling with these challenging conditions. With a commitment to transformative discoveries, Clearmind Medicine sets the stage for redefining healthcare paradigms and championing the advancement of psychedelic-based therapies, with a promise to unveil a future brimming with possibilities for patients worldwide.

Follow Clearmind Medicine’s journey as it forges ahead in its quest to revolutionize healthcare through cutting-edge therapies and collaborative partnerships that mark significant milestones in the pursuit of enhancing medical care and propelling the evolution of psychedelic-based treatments.

About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.

24/7 Market News, Inc Disclaimer
Please go to https://247marketnews.com/disclaimer/ for disclaimer information.

CONTACT:
24/7 Market News
Editor@247marketnews.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.